Systemic effects of nitric oxide inhalation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 27, 1995
Grant Date -
N/A
app pub date -
Apr 6, 1993
filing date -
Apr 6, 1993
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Nitric oxide or nitric oxide releasing or delivering compounds administered by the inhalation route to humans and animals in need thereof have a systemic and pulmonary effect of preventing or treating blood platelet aggregation and coagulation and thus, are useful for the prevention or treatment of systemic platelet aggregation, pulmonary emboli, angina pectoris and acute respiratory distress syndrome.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully